<?xml version="1.0" encoding="UTF-8"?>
<p>Primary prevention of dengue through vector control activities has had limited success worldwide 
 <xref rid="pntd.0001614-Morrison1" ref-type="bibr">[9]</xref>. Currently, no vaccine exists to prevent dengue nor is there an anti-viral treatment. However, secondary prevention to reduce mortality through improved clinical case management has substantially lowered the mortality rate for severe dengue from 10â€“20% to &lt;1% in some countries over the past two decades 
 <xref rid="pntd.0001614-Kalayanarooj1" ref-type="bibr">[10]</xref>, 
 <xref rid="pntd.0001614-Lan1" ref-type="bibr">[11]</xref>. To begin to understand patient care and management issues related to dengue associated deaths including under-recognition of severe dengue, we performed a review of medical records from the case-series of all laboratory-positive fatal cases in Puerto Rico that occurred during the 2007 epidemic.
</p>
